Indian drugmaker Divi's misses June-quarter profit view on weak US pricing
The Hyderabad-based company's consolidated net profit rose 26.7% to 5.45 billion rupees ($62 million) for the quarter ended June 30.
Analysts, on average, had expected 5.75 billion rupees, as per data compiled by LSEG.
Indian generic drugmakers, which get a significant chunk of their revenue from the U.S., have been grappling with weak pricing amid stiff competition in the region.
Divi's, one of India's largest manufacturers of active pharmaceutical ingredients (API), has flagged pricing pressure and high competition in its generics business in global markets, adding that it aims to increase its market share by launching molecules as they get off patent.
APIs are key chemical components in a drug that produce the intended therapeutic effects. Divi's exports to more than 100 countries, with the U.S. and Europe being its core markets
The company's shares were down 2.5% before the news, in tandem with the rest of the pharma stocks on U.S. President Donald Trump's potential tariff threat.
India's Pidilite posts higher quarterly profit on strong demand; announces bonus issue
The drugmaker's peers Cipla and Dr Reddy's also reported subdued June-quarter sales in the U.S.
Revenue from operations for Divi's rose 14% to 24.10 billion rupees, also missing analysts' estimates of 24.56 billion rupees.
The company is banking on demand from diabetes and weight-loss drugs manufacturers such as Eli Lilly, who cater to skyrocketing customer demand for the drug in global markets.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
2 hours ago
- Business Recorder
Australia, NZ dollars set for weekly gains, RBA policy meet next week
SYDNEY: The Australian and New Zealand dollars were set for weekly gains on Friday with the U.S. dollar burdened by weak economic data and dovish bets for policy easing, slipping back towards its three-year lows. The Aussie eased 0.2% to $0.6513, having edged up 0.3% overnight to as high as $0.6541. It is running into resistance around $0.6540 but is still up 0.6% on the week, offsetting some of last week's 1.4% fall. The kiwi dollar was steady at $0.5960, after gaining 0.6% overnight to mark the second straight day of gains. It is up 0.7% for the week, with resistance at around 60 cents. The two Antipodean currencies have largely tracked movements in the U.S. dollar, which fell slightly overnight after President Donald Trump announced Stephen Miran as his pick to serve out the final few months of a newly vacant seat at the Federal Reserve. That stoked expectations for a dovish pick to replace chair Jerome Powell, who Trump has lashed out against for not lowering interest rates. The dollar index fell 0.6% this week to 98.131, not far above its three-year trough of 96.373. Looking ahead, the Reserve Bank of Australia will meet next week and is widely expected to cut interest rates by a quarter-point to 3.6% on Tuesday, after shocking markets last month to hold rates steady. The RBA will also publish updated economic forecasts. 'We expect the GDP track being lowered and the unemployment rate being raised as supporting further cuts to the target cash rate,' said analysts at TD Securities in a note to clients. 'Short term valuations and positioning are cleaner in the USD… which could allow AUD to break above 66 cents if the RBA surprises to the hawkish side.' Markets are fully priced for a move on Tuesday, with a slim chance of an outsized 50 basis point cut. The central bank has emphasised it wants to be gradual and cautious in easing, so investors generally assume rates will be held steady at the September meeting and will be cut again in November. Across the Tasman Sea, markets imply around an 87% chance of a quarter-point cut from the Reserve Bank of New Zealand to 3.0% on August 20, and the possibility of a further move to a floor of 2.75% late this year or early next.
Business Recorder
3 hours ago
- Business Recorder
India bonds edge down in thin trade before debt sale
MUMBAI: Indian government bonds dipped in early trading on Friday, as investors remained wary ahead of the weekly debt sale that will test demand in the wake of a disappointing central bank policy decision. The yield on the benchmark 10-year bond was at 6.3949%, as of 10:20 a.m. IST, while it closed at 6.3861% on Thursday. Bond yields move inversely to prices. New Delhi is set to raise 250 billion rupees ($2.86 billion)through the sale of seven-year and 50-year bonds in the debt auction later in the day. The RBI's decision to hold rates and a lack of dovish cues in the Governor's statement had pared rate easing bets. It has curbed investor appetite for debt, traders said, adding that demand for auction will be key for determining direction of bond yields. 'The uncertainties appear to have increased for bonds,' said Sandeep Bagla, CEO at Trust Mutual Fund. 'With core inflation stubbornly high and headline inflation projected at 4.9% after a few months, there seems to be little room for an immediate rally.' Market participants are now awaiting next quarter's GDP data by August-end for cues on the RBI's policy easing trajectory. U.S. President Donald Trump's 50% tariffs on Indian imports could hurt India's growth prospects as it would curtail India's ambitions to develop its manufacturing sector and hurt its garment makers.
Business Recorder
3 hours ago
- Business Recorder
Banks, energy stocks drag Australia shares lower
Australian shares inched lower on Friday as banks and energy stocks declined, while investors braced for peak corporate earnings and the local central bank's rate decision next week. The S&P/ASX 200 index eased 0.1% to 8,827.10 points by 0048 GMT. It had slipped below the psychologically key 8,800-level to 8,794.50 points earlier in the day. Market participants are now awaiting results from some of the largest Australian companies next week, including the Commonwealth Bank of Australia (CBA), Westpac and ANZ Group. On the local bourse, financials fell 0.4%, with three of the 'Big Four' banks losing between 0.2% and 0.5%. QBE Insurance lost 4.1% despite beating market estimates for half-year interim earnings. Energy stocks fell 0.3% as oil slipped for the sixth straight session after the Kremlin said President Vladimir Putin would meet U.S. President Donald Trump in the coming days, raising hopes for a diplomatic end to the war in Ukraine. Woodside Energy and Santos shed 0.7% and 0.1%, respectively. Meanwhile, miners rose 1.2%, capping losses on the benchmark, with Rio Tinto and BHP gaining 0.8% and 0.9%, respectively. Gold stocks advanced 1.6% tracking a jump in bullion prices, buoyed by safe-haven demand after Trump's tariffs took effect. Evolution Mining rose 1.5%. New Zealand's benchmark S&P/NZX 50 index inched 0.1% higher to 12,902.88 points.
